Source: Reapplix Vimeo Channel

Followers on Owler

101

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

CEO

Kira Rupprecht

CEO Approval Rating

82/100

Reapplix is a Denmark-based biotechnology company that develops and commercializes novel therapeutics for the treatment of diabetic foot ulcers.

Reapplix posted a video "3C Patch - Living cells in wound healing" on VIMEO